BRITTANY SANDS: Open Payments
NPI 1033450689 · WARRINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,202 in 70 payments from 16 companies in 2025. Trend: 2023 $1,427 · 2024 $1,583 · 2025 $1,202
Food & beverage: $1,202
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $238 |
| Novo Nordisk Inc | 12 | $186 |
| ABBVIE INC. | 12 | $161 |
| PFIZER INC. | 6 | $118 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| Lilly USA, LLC | 5 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Amgen Inc. | 3 | $50 |
| Inspire Medical Systems, Inc. | 2 | $49 |
| Merck Sharp & Dohme LLC | 2 | $46 |
Products named: UBRELVY, AIRSUPRA, MOUNJARO, FARXIGA, Wegovy, JARDIANCE, SHINGRIX, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
